Labcorp Early Development Services GmbH
About us
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.
Address
Kesselfeld 29
48163 Münster
Germany
E-mail: info@labcorp.com
Phone: +49 251 3274-9000
Internet: www.labcorp.com/
Contact person:
Dr. Gerald Pöltl
E-mail: gerald.poeltl@labcorp.com
Products & Services
Toxicology: Reduce risk and move your program more efficiently across critical milestones with our strategic insights and comprehensive capabilities from general to specialty toxicology performed in all species, through all routes of administration and for all modalities. https://www.labcorp.com/biopharma/nonclinical/disciplines/toxicology
Discovery: Fast forward your candidate selection with our scientific experience, suite of standard and custom discovery biology testing solutions and rapid data delivery. Our portfolio includes Pharmacology, DMPK and Early Safety solutions. https://www.labcorp.com/biopharma/nonclinical/stages/discovery
Discovery Oncology: Leverage our 20+ years of discovery oncology experience, 430+ human and syngeneic tumor models, 300+ patient-derived xenograft models and expertise in immuno-oncology and adoptive cell therapy to advance your oncology research. https://www.labcorp.com/biopharma/nonclinical/therapeutics/oncology
Early Phase Development Solutions: Accelerate your molecule’s success with a programmatic approach to drug development that advances your molecule swiftly through critical milestones while maximizing its value. Our Early Phase Development Solutions can help you reach your program goals up to 30% faster with a proactive strategy, world-class drug development team and efficient program management. https://www.labcorp.com/biopharma/nonclinical/stages/integration
MarketPlace: Find the right licensing or investment partner with MarketPlace, our exclusive digital partnering platform that facilitates secure connections between Asset Providers seeking licensing partners and Asset Seekers—pharmaceutical companies, medtech, biotechs and investors—looking to enhance their portfolios. https://www.labcorp.com/biopharma/nonclinical/stages/assets